Servillo, Andrea
Sacconi, Riccardo
Oldoni, Gloria
Barlocci, Eugenio
Tombolini, Beatrice
Battista, Marco
Fantaguzzi, Federico
Rissotto, Federico
Mularoni, Cecilia
Parravano, Mariacristina
Zucchiatti, Ilaria
Querques, Lea
Bandello, Francesco
Querques, Giuseppe http://orcid.org/0000-0002-3292-9581
Article History
Received: 22 March 2024
Accepted: 13 May 2024
First Online: 4 June 2024
Declarations
:
: The authors report there are no competing interests to declare. This report does not contain any personal information that could lead to the identification of the patients. Riccardo Sacconi has the following disclosures: Abbvie, Bayer, Medivis, Novartis, Roche, and Zeiss. Francesco Bandello has the following disclosures: Allergan, Bayer, Boehringer-Ingelheim, Fidia Sooft, Hofmann La Roche, Novartis, Ntc Pharma, Sifi, Thrombogenics, Zeiss. Giuseppe Querques has the following disclosures: Alimera Sciences, Allergan Inc, Amgen, Heidelberg, KBH, LEH Pharma, Lumithera, Novartis, Bayer Shering-Pharma, Sandoz, Sifi, Soof-Fidia, Zeiss. Giuseppe Querques is an Editorial Board member of Ophthalmology and Therapy. Giuseppe Querques was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Andrea Servillo, Gloria Oldoni, Eugenio Barlocci, Beatrice Tombolini, Marco Battista, Federico Fantaguzzi, Federico Rissotto, Cecilia Mularoni, Mariacristina Parravano, Ilaria Zucchiatti, and Lea Querques have nothing to declare.
: This article is based on previous research; therefore, no approval from the local ethics committee was required.